Literature DB >> 16359744

Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.

Yasuo Ejima1, Ryohei Sasaki, Yoshiaki Okamoto, Tsutomu Maruta, Atsushi Azumi, Yoshitake Hayashi, Yusuke Demizu, Yosuke Ota, Toshinori Soejima, Kazuro Sugimura.   

Abstract

Forty-two patients with stage IE ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma were retrospectively analyzed. Five-year local control and progression-free survival rates were 100 and 77%, respectively. The most common relapsed site was the contralateral orbit. Thirty Gy of local irradiation seemed to be quite effective and safe.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359744     DOI: 10.1016/j.radonc.2005.11.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  18 in total

1.  Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience.

Authors:  M Smiljanic; R Milosevic; D Antic; B Andjelic; V Djurasinovic; M Todorovic; J Bila; A Bogdanovic; B Mihaljevic
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

Review 2.  Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Clin Exp Med       Date:  2017-09-22       Impact factor: 3.984

3.  Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.

Authors:  Soley Bayraktar; Ulas D Bayraktar; Alexandra Stefanovic; Izidore S Lossos
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

Review 4.  Extranodal marginal zone lymphoma of the ocular adnexa.

Authors:  Alexandra Stefanovic; Izidore S Lossos
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

Review 5.  A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma.

Authors:  Maurilio Ponzoni; Silvia Govi; Giada Licata; Silvia Mappa; Antonio Giordano Resti; Letterio S Politi; Lorenzo Spagnuolo; Eliana Di Cairano; Claudio Doglioni; Andrés J M Ferreri
Journal:  Oncologist       Date:  2013-06-28

6.  Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.

Authors:  M Hata; I Koike; J Maegawa; A Kaneko; K Odagiri; T Kasuya; Y Minagawa; H Kaizu; Y Mukai; T Inoue
Journal:  Strahlenther Onkol       Date:  2012-10-28       Impact factor: 3.621

Review 7.  Chlamydial infection: the link with ocular adnexal lymphomas.

Authors:  Andrés J M Ferreri; Riccardo Dolcetti; Simone Magnino; Claudio Doglioni; Maurilio Ponzoni
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

8.  Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.

Authors:  Andrés J M Ferreri; Marianna Sassone; Elisabetta Miserocchi; Silvia Govi; Caterina Cecchetti; Matteo E Corti; Silvia Mappa; Luca Arcaini; Francesco Zaja; Giuseppe Todeschini; Donato Mannina; Teresa Calimeri; Salvatore Perrone; Maurilio Ponzoni; Giulio Modorati
Journal:  Blood Adv       Date:  2020-03-24

9.  Extranodal Marginal Zone Lymphoma of Ocular Adnexa: Outcomes following Radiation Therapy.

Authors:  Sean Platt; Yahya Al Zahrani; Nakul Singh; Brian Hill; Sheen Cherian; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2017-02-02

10.  Orbital lymphoma: diagnostic approach and treatment outcome.

Authors:  André M Eckardt; Juliana Lemound; Majeed Rana; Nils-Claudius Gellrich
Journal:  World J Surg Oncol       Date:  2013-03-18       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.